KCM

Knoll Capital Management Portfolio holdings

AUM $141M
This Quarter Return
+20.68%
1 Year Return
+51.8%
3 Year Return
+256.4%
5 Year Return
+482.18%
10 Year Return
+5,137.57%
AUM
$257M
AUM Growth
+$257M
Cap. Flow
-$333K
Cap. Flow %
-0.13%
Top 10 Hldgs %
99.62%
Holding
17
New
2
Increased
1
Reduced
2
Closed
2
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
MDVN
1
DELISTED
MEDIVATION, INC.
MDVN
$222M 86.32% 2,244,519 -35,000 -2% -$3.46M
AMPE
2
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
$12M 4.67% 3,370,822 +406,421 +14% +$1.45M
ARCT icon
3
Arcturus Therapeutics
ARCT
$462M
$10.6M 4.13% 687,000
KERX
4
DELISTED
Keryx Biopharmaceuticals Inc
KERX
$2.75M 1.07% 200,000
ENLV icon
5
Enlivex Therapeutics
ENLV
$25M
$2.46M 0.96% +338,110 New +$2.46M
TOVX icon
6
Theriva Biologics
TOVX
$3.94M
$2.39M 0.93% 1,360,000
LUMO
7
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
$1.66M 0.65% 77,437
INO icon
8
Inovio Pharmaceuticals
INO
$126M
$1.01M 0.39% 102,088
ADXS
9
DELISTED
Advaxis, Inc.
ADXS
$756K 0.29% 225,000
GLMD icon
10
Galmed Pharmaceuticals
GLMD
$6.96M
$559K 0.22% 65,000
NWBO
11
DELISTED
Northwest Biotherapeutics, Inc. Common stock
NWBO
$337K 0.13% 67,035 -133,265 -67% -$670K
NRX
12
DELISTED
NEPHROGENEX INC COM
NRX
$234K 0.09% 50,000
PVCT
13
DELISTED
PROVECTUS BIOPHARMACEUTICALS, INC. (DE)
PVCT
$204K 0.08% 200,000
ADXSW
14
DELISTED
Advaxis, Inc. Warrants
ADXSW
$162K 0.06% 112,500
CLRB icon
15
Cellectar Biosciences
CLRB
$15.5M
$33K 0.01% +14,634 New +$33K
AKTX
16
Akari Therapeutics
AKTX
$24.8M
-14,155 Closed -$78K
ECTE
17
DELISTED
ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE)
ECTE
-27,430 Closed -$62K